$0.85 -0.04 (-4.93%)
2/10/2012 4:00 PM

BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Featured Broker Partners


Advertisement